Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
NEIMO

Major Cross-functional project NEIMO

Last update: 27/06/2025 Reading time: 1min

Understanding neuroinflammation to cure brain diseases, and Paris Brain Institute-Yale collaboration

The context

Neuroinflammation contributes to the onset and progression of many neurologial diseases, especially MS and PD. Characterizing undesratding and controlling neuroinflammation may help predict disease onset and progression, and improve therpeutic approaches.
To date, there are no procedures for simultaneously mapping and profiling the cellular and molecular states of neuroinflammation. This technological bottleneck is limiting the early diagnosis, progression assessment and prognosis of neurological diseases, and most importantly, is limiting early interventional therapies.

The project's goals

The project's goals

The main goal of the NEIMO program is to generate and integrate the most advanced procedures to simultaneously image and profile the cellular and molecular states of neuroinflammation in multiple sclerosis and early Parkinson’s disease, to know how monitoring neuroinflammation can inform the prediction of disease onset and the assessment of its progression and response to treatments. 
The Yale School of Medicine and Paris brain Institute partners provide exceptional equipment and methodological expertise from leaders in the fields of brain imaging and neuroimmunology, as well as a strong history of collaboration and complementary expertise in neurobiology, immunology, vascular biology, brain imaging and computer science.

Aim 1. Monitor neurinflammatory mechanisms in patients. 

Focusing on lymphatic dysfunction and inflammation, we will investigate early events leading to the onset diseases in early-stage Multiple Sclerosis and REM-sleep Behavior Disorder patients from both Yale and the Paris Brain Institute. The goal is to understand disease onset and progression through molecular profiling in blood and other samples, with a focus on single cell RNA-seq and cytokine measurements.


Aim2. Image brain fluid drainage and neuroinflammation. 

We will leverage recent advances in imaging techniques to track fluid drainage and neuroinflammation in early MS, RBD, and idiopathic intracranial hypertension (IIH), by using MRI and PET-MRI imaging. We aim to identify early disease biomarkers and potential therapeutic targets, with imaging markers correlating with inflammation levels.

Aim 3. Generate AI-assisted methods to automate data analysis. 

We will create AI tools to automatize the extraction and integration of neuroimaging and omics data, enabling the identification of neuroinflammatory signatures in a cross-modal approach (e.g. with causal inference frameworks).
 

Aim 4. Generate new predictive models of disease progression. 

We will develop novel statistical models to describe disease progression, predict clinical outcomes, and identify subtypes based on neuroinflammation markers. We will compare various modeling approaches to track disease trajectories and predict clinical outcomes, particularly in RBD, MS, and IIH.


Aim 5. Spread open-source AI tools through an interactive platform. 

We will promote scientific and clinical use of developed datasets and tools through open-source AI tools, softwares and datasets, organized data challenges, and patented methods.
ées et de méthodes brevetées.

News that might interest you

Le cortex moteur
Origin of Lance-Adams Syndrome Finally Elucidated
First described 60 years ago, chronic myoclonus following cerebral anoxia is now known as Lance-Adams syndrome. This is a severe disorder whose mechanisms were, until now, poorly understood. Geoffroy Vellieux, Vincent Navarro, and their colleagues at...
06.16.2025 Research, science & health
Tiré de New Theory of Colours de Mary Gartside, 1808
Aphantasia Might Be Linked to Alterations in Brain Connectivity
Thanks to 7T fMRI, researchers from Paris Brain Institute and NeuroSpin, the CEA's neuroimaging centre, are exploring the neural substrate of visual imagery at very high resolution for the first time. Their results, publiés [i] in Cortex, pave the...
06.06.2025 Research, science & health
Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
See all our news